The global sodium starch glycolate market is projected to rise from USD 86.70 million in 2025 to USD 91.70 million in 2026 and reach USD 125.30 million by 2031, according to a ResearchAndMarkets report added to the company's offering. The study says demand is being supported by higher generic drug production, broader use of nutraceutical tablets and capsules, and continued pharmaceutical manufacturing investment, while starch feedstock volatility remains a key restraint. Potato starch-based material held 38.7% of global market share in 2025, corn starch-based grades are forecast to post the fastest source growth at a 6.32% compound annual growth rate, Asia-Pacific led regional demand with 34.8% share in 2025, and North America is expected to expand fastest at a 5.8% compound annual growth rate through 2031. The report also points to regulatory and supply-chain shifts, including 76 first-generic drug approvals by the United States Food and Drug Administration, China's excipient Good Manufacturing Practice (production quality standard) annex taking effect on January 1, 2026, and growing reliance on harmonized grades, Drug Master File (regulatory quality dossier) support, and regional technical centers.